Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Recurrence × Thoracic × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

OTHER 49 INDUSTRY 45 NIH 2 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 19 Sarcoma 13 Other hematologic neoplasm 10 CNS 9 Plasma cell 8 Genitourinary 4 Myeloid 3 Head & Neck 3 Dermatologic 3 Breast 3 Thoracic 1 Other solid neoplasm 1 Other 1 Gynecologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 138 Lung Neoplasms 123 Adenocarcinoma of Lung 33 Small Cell Lung Carcinoma 20 Adenocarcinoma, Bronchiolo-Alveolar 16 Breast Neoplasms 13 Colorectal Neoplasms 11 Mesothelioma, Malignant 10 Colonic Neoplasms 10 Prostatic Neoplasms 8 Rectal Neoplasms 7 Breast Neoplasms, Male 7 Ovarian Neoplasms 5 Neoplasm Metastasis 5 Melanoma 5 Thymoma 4 Pleural Effusion, Malignant 4 Neoplasms 4 Carcinoma, Ovarian Epithelial 4 Uterine Cervical Neoplasms 3 Urinary Bladder Neoplasms 3 Stomach Neoplasms 3 Pain 3 Lymphoma, Large B-Cell, Diffuse 3 Fallopian Tube Neoplasms 3 Testicular Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Solitary Fibrous Tumor, Pleural 2 Sezary Syndrome 2 Salivary Gland Neoplasms 2

Interventions

Pharmaceutical Preparations 1 Lidocaine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07347977 2026-01-16

LidCRM

First Affiliated Hospital of Ningbo University

Phase NA Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡